Načítá se...
A novel anti-CD22 scFv–apoptin fusion protein induces apoptosis in malignant B-cells
CD22 marker is a highly internalizing antigen which is located on the surface of B-cells and is being used as a promising target for treatment of B cell malignancies. Monoclonal antibodies targeting CD22 have been introduced and some are currently under investigation in clinical trials. Building on...
Uloženo v:
| Vydáno v: | AMB Express |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5457376/ https://ncbi.nlm.nih.gov/pubmed/28582973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13568-017-0410-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|